%0 Journal Article
%T Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly
%A Antonio Reis Nakasato
%A Jackson Tang
%A Sameer R. Ghate
%A Zhiyi Li
%J Archive of "American Health & Drug Benefits".
%D 2018
%X Immunotherapies and targeted therapies have drastically improved survival in metastatic melanoma, but they can cause a range of adverse events (AEs). Understanding the costs of these events would facilitate an accurate comparison of melanoma treatments
%K adverse events
%K economic burden
%K elderly patients
%K immunotherapy
%K metastatic melanoma
%K targeted therapy
%K treatment-related costs
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306100/